Our Mission

The MPQC is a cooperative voluntary program involving Massachusetts maternity facilities and key perinatal stakeholders, designed to promote the sharing of best practices of care.
Success will be based on outcome measures generated from individual healthcare facilities and state agencies.
Please visit our new joint collaborative network PNQIN: HERE


Massachusetts Perinatal Quality Collaborative (MPQC) Spring Summit 2017 on Wednesday, May 24, 2017.


Highlights of the MPQC Spring Summit will include:

Keynote Presentation: Epidemiology of Maternal Mortality: Delivering Equity

Brief Description: The Persistent Challenge of Disparities in Maternal Health Outcomes with Special Attention to Maternal Mortality

  • Dr. Gene Declercq, PhD, Professor of Community Health Sciences, Boston University School of Public Health
  • Dr. Candice Belanoff, ScD, MPH, Clinical Assistant Professor, Community Health Sciences Boston University School of Public Health

Additional Topics will include....

  • Severe Maternal Morbidity and Hypertensive Disorders
  • Updates for Quality improvement Projects from around the State  
  • Progesterone & 17 Alpha‑hydroxyprogesterone caproate Toolkit Kick Off
  • Maternal Hypertension QI Project Updates           
  • Maternal Substance Use in Pregnancy QI Project Updates 

PLEASE REGISTER HERE: http://www.cvent.com/d/75q03w


17P: Clinical, Public Health & Policy Approaches to Increased Access

Please join the March of Dimes Massachusetts and stakeholders from across the Northeast to discuss how we can increase access to 17P for women with a history of prior preterm birth.

We need your voice to help inform next steps in Massachusetts and the Northeast Region.





17P: Clinical, Public Health & Policy Approaches to Increased Access
Wednesday, February 15th 2017
8:30 AM – 12:30 PM
Federal Reserve Plaza, New England Room
600 Atlantic Ave. Boston, MA 02210

Meeting Objectives:
1. Assemble a team of leaders with the authority, expertise, credibility, and motivation necessary to drive a successful initiative to increase access to 17 alpha-hydroxyprogesterone caproate and reduce preterm birth
2. Gain an understanding of clinical progress to date to inform future initiatives designed to increase access to 17 alpha-hydroxyprogesterone caproate
3. Review current Massachusetts insurance policies on progesterone
4. Develop next steps for the MA project plan to increase access to 17 alpha-hydroxyprogesterone caproate


8:00 – 8:30 Breakfast & Registration

8:30 – 9:20 Opening Plenary I
Introductory Remarks
National Perspective
Massachusetts’ Progress to Date

9:20 – 9:50 Keynote Presentation

9:50-10:00 Break

10:00-11:20 Plenary II
17P at the Institutional Level – One MA Hospital
Medicaid & Payer Policy in MA
Patient/Consumer Perspective

11:30-12:30 Q&A Panel
MA – Actionable Items and Next Steps

PNQIN Statewide Neonatal Abstitence Syndrome (NAS) and Maternal Opioid Use Fall Summit

The MPQC and NeoQIC will hold a joint fall summit on November 2nd, 2016 at the Best Western Royal Plaza Hotel in Marlborough, MA. The Joint Summit will focus on NAS and Maternal Opioid Use During Pregnacy, as well as discuss other active obstetrical and neonatal projects. Please Visit our joint collaborative website PNQIN for more information.

Please register for the upcoming MPQC and NeoQIC Joint Quality Improvement Summit: Perinatal Opioid Use and Neonatal Abstinence Syndrome. We look forward to seeing you there. Please access the registration site here or http://www.cvent.com/d/8vqzm2

MPQC and NeoQIC Joint Quality Improvement Summit3

 You are invited to attend 
Perinatal Opioid Use and Neonatal Abstinence Syndrome: Quality Improvement Efforts in Massachusetts on Wednesday, November 2, 2016
at the Best Western Royal Plaza, Marlborough, MA

Join us for a day long summit bringing together maternal and newborn clinical providers, community-based advocates, public health officials, and state leaders to review, discuss, and focus statewide efforts to improve the care of infants and families impacted by perinatal opioid use and neonatal abstinence syndrome.

There is no fee to attend this meeting. Refreshments and lunch will be provided. Unfortunately, we are not able to offer continuing education credits.

Click here for the event summary

The complete agenda will be announced soon. Highlights include:

  • Keynote Address: Improving the Care of Mothers and Infants Impacted by Substance Use: The Ohio State Collaborative Experience, Scott Wexelblatt, MD Medical Director, Regional Newborn Services, Cincinnati Children’s Hospital Medical Center
  • Updates from the State Office of the Attorney General and the Governor’s Opioid Working Group Early Intervention Bureau of Substance Abuse Services Department of Children and Families Health Policy Commission
  • Clinical Quality Improvement Toolkit for management of mothers and infants impacted by perinatal opioid use
  • Updates on hospital quality improvement efforts Proposal for renewed statewide hospital-based quality improvement initiative 
  • Breakout Sessions Early Intervention pilot project MPQC toolkit Quality improvement tools and techniques
  • Quality measures for perinatal opioid use and neonatal abstinence syndrome


 We look forward to seeing you there! 

If you have difficulty copy and paste: http://www.cvent.com/d/8vqzm2
into your internet browser



Cvent - Web-based Software Solutions

The Zika Virus and Microcephaly- What you need to know?

The possible link between a mosquito carrying the Zika virus and an increase in babies born with microcephaly, a birth defect, is being investigated in Brazil.


According to the CDC: “Outbreaks of Zika have occurred in areas of Africa, Southeast Asia, the Pacific Islands, and the Americas. Because the Aedes species mosquitoes that spread Zika virus are found throughout the world, it is likely that outbreaks will spread to new countries. In December 2015, Puerto Rico reported its first confirmed Zika virus case. Locally transmitted Zika has not been reported elsewhere in the United States, but cases of Zika have been reported in returning travelers.”


There is no cure for the Zika virus. If you are pregnant and have been to an affected area, watch for signs of the virus and seek the advice of your prenatal health care provider. Symptoms include fever with muscle or eye pain, and a possible rash during the next two weeks.


http://www.marchofdimes.org/zika -English Articles/Blog Updates

http://www.nacersano.org/zika - Spanish Articles/Blog Updates


CDC on Zika Virus here.

Massachusetts Department of Public Health Guidance on Zika Virus
DPH Zika Advisory 1-21-2016.pdf
Adobe Acrobat document [71.3 KB]
What Clinicians need to Know on Zika Virus
Adobe Acrobat document [2.0 MB]

Fewer Babies Born Before Full Term

"Efforts by hospitals and government officials to decrease the percentage of babies born before full term appear to be paying off in Massachusetts and nationwide, according to a new report.


Last year, Massachusetts hospitals performed just over 1 percent of their deliveries on average as early elective deliveries, via scheduled induced deliveries or cesarean sections for no medical reason, before 39 weeks, compared with a statewide rate of 15 percent in 2010."


Read the full story here.

Website Administrator

Jack Mourad

Massachusetts Perinatal Quality Collaborative


112 Turnpike Rd
Suite 300
Westborough, MA 01581

(508) 329-2807


Print Print | Sitemap
© Massachusetts Perinatal Quality Collaborative